ARTICLE | Clinical News
Gensia Inc. regulatory update
April 10, 1995 7:00 AM UTC
GNSA's Gensia Laboratories Ltd. subsidiary received FDA approval of its ANDA for a generic version of injectable amphotericin B to treat fungal infections. Gensia Laboratories (Irvine, Calif.) now has...